MarketInOut Stock Screener Log In | Sign Up
 

Illumina Inc

NASDAQ • Healthcare • Diagnostics & Research • Quote as of 10/23/2026
Illumina Inc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization40,679 mln
Float151 mln
Earnings Date10/29/2026

EPS

5.10
Stretched

P / E

52.83
Richly valued

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.59
Likely reliable

1-Year Forecast

245.80
Limited downside

Relative Strength

42 / 100
Slightly lagging

Business Description

Illumina is a San Diego-based company founded in 1998 that makes tools and equipment for reading and analyzing DNA. Its products are used by research institutions, hospitals, pharmaceutical companies, and diagnostic labs across the Americas, Europe, Asia, the Middle East, and Africa. The company also offers services such as prenatal testing and cancer-related genomic analysis, and works with partners like Labcorp and the Center for Data-Driven Discovery in Biomedicine to advance research in oncology, pediatric cancer, and rare diseases.

Key Fundamentals

EPS5.10
P/E52.83
ROE32.04
RPS29.57
ROIC15.08
ROA12.84
Interest Cover9.02
EBITDA, mln1,387
EV / EBITDA31.02
EV / EBIT38.62
Revenue, mln4,495
EV / Revenue9.57

Quote Details

Last 269.42
Change 0.02 (0.01%)
Open 264.42
Volume 1,262,688
Turnover 340,193,408
Average Volume 2,596,411

Financial Ratios

Pre-Tax Profit Margin23
Leverage Ratio2.34
Current Ratio1.80
Price / Book14.55
Price / Tangible Book36.10
Price / Cash Flow37.15
Price / Free Cash Flow45.23
Debt / Equity0.89
Price / Sales9.37
PEG Ratio3.49

Financial Strength

Altman Z-Score7.91
Piotroski F-Score 6 / 9
Beneish M-Score-2.59
Price to Intrinsic Value5.59
Price to Graham Number9.67
1-Year Target Price245.80
Short Ratio2.43
Short % of Float10.26

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 2.62% 82 / 100   
1 Month -1.64% 53 / 100   
2 Months 45.88% 97 / 100   
6 Months 111% 98 / 100   
1 Year 177% 99 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog